Director/PDMR Shareholding

Summary by AI ^BETAClose X

Primary Health Properties PLC has announced that Harry Hyman, Non-executive Chair, purchased 4,150 ordinary shares at a price of £1.01341 per share on March 13, 2026, through an ISA under a dividend re-investment plan, for a total transaction value of £4,205.65 on the London Stock Exchange.

Disclaimer*

Primary Health Properties PLC

16 March 2026

Primary Health Properties PLC

("PHP" or the "Company"),

Director/PDMR Shareholding

The Company has been notified that the following information relating to the transaction detailed below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation.

1	Details of person discharging managerial responsibilities/person closely associated
(a)	Name	Harry Hyman
2	Reason for notification
(a)	Position/Status	Non-executive Chair
(b)	Initial notification/amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)	Name	Primary Health Properties PLC
(b)	LEI	213800Y5CJHXOATK7X11
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)	Description of the financial instrument	Ordinary shares of 12.5p ISIN: GB00BYRJ5J14
(b)	Nature of the transaction	Purchase by ISA under dividend re-investment plan
(c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£ 1.01341	4,150
(d)	Aggregated volume price	Single transaction £4,205.65
(e)	Date of transaction	13 March 2026
(f)	Place of transaction	London Stock Exchange (xlon)

For further information:

Primary Health Properties PLC

David Purcell Investor Relations

Primary Health Properties PLC

T: +44 (0) 7921 190 136

E: david.purcell@phpgroup.co.uk

Sodali & Co Financial PR

Elly Williamson/Louisa Henry/Saskia Bottomley

T: +44 (0) 207 250 1446 E: PHP@client.sodali.com

Legal Entity Identifier: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END